# A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules

> **NCT00281606** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 65 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Different formulations of once-daily lopinavir/ritonavir

## Key facts

- **NCT ID:** NCT00281606
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02-14
- **Primary completion:** 2007-10-16
- **Final completion:** 2012-06-13
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00281606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00281606, "A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00281606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*